Legal & General Group’s Kestra Medical Technologies KMTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$407K Hold
14,374
– – ﹤0.01% 2427
2026
Q2
$366K Buy
14,374
+1,548
+12% +$32.4K ﹤0.01% 2467
2026
Q1
$256K Sell
12,826
-1,760
-12% -$41.5K ﹤0.01% 2496
2025
Q4
$387K Buy
14,586
+13,152
+917% +$339K ﹤0.01% 2483
2025
Q3
$34K Hold
1,434
– – ﹤0.01% 2830
2025
Q2
$23.8K Buy
1,434
+434
+43% +$9.48K ﹤0.01% 2939
2025
Q1
$24.9K Buy
+1,000
New +$23K ﹤0.01% 2873

Other funds holding KMTS

Legal & General Group's KMTS Position: Q3 2026 in Review

Legal & General Group held its Kestra Medical Technologies (KMTS) position steady in Q3 2026 at 14,374 shares worth $407K. The position accounts for ﹤0.01% of the portfolio, ranked #2427.

Legal & General Group first reported a position in KMTS in Q1 2025 and has held it in 7 quarters since. 122 funds tracked by Wall St. Rank hold KMTS as of Q3 2026.

  • Legal & General Group held 14,374 shares of Kestra Medical Technologies worth $407K as of Q3 2026.
  • Legal & General Group left its Kestra Medical Technologies share count unchanged in Q3 2026.
  • Kestra Medical Technologies made up ﹤0.01% of Legal & General Group's portfolio in Q3 2026, its #2427 holding.
  • Legal & General Group first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 7 quarters since.
  • 122 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q3 2026.

Based on Legal & General Group's 13F filing for Q3 2026, filed 16 Nov 2026.